Perbedaan Jakarta Setiabudi Internasional Tbk dan Brigit Biofarmaka Teknologi Tbk.: Jakarta Setiabudi Internasional Tbk diperdagangkan di Rp1.415 (kapitalisasi pasar 3,25 T, volume 24 jam 7,5 rb), sedangkan Brigit Biofarmaka Teknologi Tbk. diperdagangkan di Rp248 (kapitalisasi pasar 167,37 M, volume 24 jam 96,7 rb). Perbedaan utamanya: Jakarta Setiabudi Internasional Tbk jauh lebih besar — sekitar 19,4× kapitalisasi pasar Brigit Biofarmaka Teknologi Tbk., dan Brigit Biofarmaka Teknologi Tbk. lebih aktif diperdagangkan (96,7 rb vs 7,5 rb). Mana yang lebih baik tergantung tujuan investasimu.
| JSPT | OBAT | |
|---|---|---|
Kapitalisasi Pasar | 3,25 T | 167,37 M |
Volume | 7,5 rb | 96,7 rb |
Lot | 75 | 967 |
Perputaran | 10,56 jt | 23,82 jt |
Harga Rata-rata | 1.408 | 246,34 |
Nilai Transaksi | 10,56 jt | 23,82 jt |
Harga Ekuilibrium Indikatif | — | 248 |
Volume Ekuilibrium Indikatif | — | 41 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT. Jakarta Setiabudi Internasional Tbk (the Company) was established in the Republic of Indonesia within the framework of the Domestic Capital Investment Law No. 6 year 1968 as amended by Law No. 12 year 1970 based on Notarial Deed No. 4 dated July 2, 1975 of Imas Fatimah, S.H., as amended by Notarial Deed No. 15 dated September 11, 1975 of the same notary. At the first time until 1996 this company was focusing in construction. Leasing and office building maintanance and apartment surrounding Kuningan area, Jakarta.
Selengkapnya di halaman JSPT →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Selengkapnya di halaman OBAT →